Login to Your Account

Pharmas Look Externally for Innovation

Multiple Strategies Employed To Build Early Stage Pipelines

By Brian Orelli
BioWorld Insight Contributing Writer

Monday, March 18, 2013

Successfully developing drugs is the ultimate goal of pharmaceutical companies, but the downside is that the pipeline requires constant replenishing. The early stage drought was made worse by the merger of large pharmaceutical companies; as the pipelines came together, the later-stage compound usually got priority when there was redundancy.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription